Table of Contents Author Guidelines Submit a Manuscript
Disease Markers
Volume 2017, Article ID 6136401, 8 pages
https://doi.org/10.1155/2017/6136401
Research Article

CACNA1B (Cav2.2) Overexpression and Its Association with Clinicopathologic Characteristics and Unfavorable Prognosis in Non-Small Cell Lung Cancer

1Department of Respiratory Medicine, The First Affiliated Hospital of Soochow University, Suzhou, China
2Department of Respiratory Medicine, Affiliated Hospital of Nantong University, Nantong, Jiangsu 226001, China
3Department of Pathology, Affiliated Hospital of Nantong University, Nantong, Jiangsu 226001, China
4Department of Laboratory Medicine, Affiliated Hospital of Nantong University, Nantong, Jiangsu 226001, China

Correspondence should be addressed to Jianan Huang; moc.621@tnnanaijgnauh

Received 13 July 2016; Revised 5 September 2016; Accepted 8 September 2016; Published 3 January 2017

Academic Editor: Stamatios E. Theocharis

Copyright © 2017 Xiaoyu Zhou et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. Q.-Y. Hong, G.-M. Wu, G.-S. Qian et al., “Prevention and management of lung cancer in China,” Cancer, vol. 121, supplement 17, pp. 3080–3088, 2015. View at Publisher · View at Google Scholar · View at Scopus
  2. C. Zhou, “Lung cancer molecular epidemiology in China: recent trends,” Translational Lung Cancer Research, vol. 3, no. 5, pp. 270–279, 2014. View at Publisher · View at Google Scholar · View at Scopus
  3. J. Ferlay, I. Soerjomataram, R. Dikshit et al., “Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012,” International Journal of Cancer, vol. 136, no. 5, pp. E359–E386, 2015. View at Publisher · View at Google Scholar · View at Scopus
  4. W. Chen, R. Zheng, H. Zeng, and S. Zhang, “Epidemiology of lung cancer in China,” Thoracic Cancer, vol. 6, no. 2, pp. 209–215, 2015. View at Publisher · View at Google Scholar · View at Scopus
  5. R. Zheng, H. Zeng, T. Zuo et al., “Lung cancer incidence and mortality in China, 2011,” Thoracic Cancer, vol. 7, no. 1, pp. 94–99, 2016. View at Publisher · View at Google Scholar · View at Scopus
  6. G. Antonelli, M. Libra, V. Panebianco et al., “Molecular-targeted therapy for elderly patients with advanced non-small cell lung cancer,” Oncology Letters, vol. 11, no. 1, pp. 3–8, 2016. View at Publisher · View at Google Scholar · View at Scopus
  7. C. Ho, K. M. Tong, K. Ramsden, D. N. Ionescu, and J. Laskin, “Histologic classification of non-small-cell lung cancer over time: reducing the rates of not-otherwise-specified,” Current Oncology, vol. 22, no. 3, pp. e164–e170, 2015. View at Publisher · View at Google Scholar · View at Scopus
  8. P. McElnay and E. Lim, “Adjuvant or neoadjuvant chemotherapy for NSCLC,” Journal of Thoracic Disease, vol. 6, no. 2, pp. S224–S227, 2014. View at Publisher · View at Google Scholar · View at Scopus
  9. S. K. Padda, B. M. Burt, N. Trakul, and H. A. Wakelee, “Early-stage non-small cell lung cancer: surgery, stereotactic radiosurgery, and individualized adjuvant therapy,” Seminars in Oncology, vol. 41, no. 1, pp. 40–56, 2014. View at Publisher · View at Google Scholar · View at Scopus
  10. M. Burotto, A. Thomas, D. Subramaniam, G. Giaccone, and A. Rajan, “Biomarkers in early-stage non-small-cell lung cancer: current concepts and future directions,” Journal of Thoracic Oncology, vol. 9, no. 11, pp. 1609–1617, 2014. View at Publisher · View at Google Scholar · View at Scopus
  11. E. Carafoli and J. Krebs, “Why calcium? How calcium became the best communicator,” Journal of Biological Chemistry, vol. 291, no. 40, pp. 20849–20857, 2016. View at Publisher · View at Google Scholar
  12. M. D. Mark, J. C. Schwitalla, M. Groemmke, and S. Herlitze, “Keeping our calcium in balance to maintain our balance,” Biochemical and Biophysical Research Communications, 2016. View at Publisher · View at Google Scholar · View at Scopus
  13. D. E. Clapham, “Calcium signaling,” Cell, vol. 131, no. 6, pp. 1047–1058, 2007. View at Publisher · View at Google Scholar · View at Scopus
  14. G. R. Monteith, D. McAndrew, H. M. Faddy, and S. J. Roberts-Thomson, “Calcium and cancer: targeting Ca2+ transport,” Nature Reviews Cancer, vol. 7, no. 7, pp. 519–530, 2007. View at Publisher · View at Google Scholar · View at Scopus
  15. C.-Y. Wang, M.-D. Lai, N. N. Phan, Z. Sun, and Y.-C. Lin, “Meta-analysis of public microarray datasets reveals voltage-gated calcium gene signatures in clinical cancer patients,” PLOS ONE, vol. 10, no. 7, Article ID e0125766, 2015. View at Publisher · View at Google Scholar · View at Scopus
  16. I. Azimi, S. J. Roberts-Thomson, and G. R. Monteith, “Calcium influx pathways in breast cancer: opportunities for pharmacological intervention,” British Journal of Pharmacology, vol. 171, no. 4, pp. 945–960, 2014. View at Publisher · View at Google Scholar · View at Scopus
  17. K. R. Loughlin, “Calcium channel blockers and prostate cancer,” Urologic Oncology, vol. 32, no. 5, pp. 537–538, 2014. View at Publisher · View at Google Scholar · View at Scopus
  18. L. Zhuang, J.-B. Peng, L. Tou et al., “Calcium-selective ion channel, CaT1, is apically localized in gastrointestinal tract epithelia and is aberrantly expressed in human malignancies,” Laboratory Investigation, vol. 82, no. 12, pp. 1755–1764, 2002. View at Publisher · View at Google Scholar · View at Scopus
  19. H.-J. Zhang, D.-F. Yao, M. Yao et al., “Annexin A2 silencing inhibits invasion, migration, and tumorigenic potential of hepatoma cells,” World Journal of Gastroenterology, vol. 19, no. 24, pp. 3792–3801, 2013. View at Publisher · View at Google Scholar · View at Scopus
  20. Q. Wang, Q. Ni, X. Wang, H. Zhu, Z. Wang, and J. Huang, “High expression of RAB27A and TP53 in pancreatic cancer predicts poor survival,” Medical Oncology, vol. 32, no. 1, p. 372, 2015. View at Publisher · View at Google Scholar · View at Scopus
  21. S. Detre, G. Saccani Jotti, and M. Dowsett, “A 'quickscore' method for immunohistochemical semiquantitation: Validation for oestrogen receptor in breast carcinomas,” Journal of Clinical Pathology, vol. 48, no. 9, pp. 876–878, 1995. View at Publisher · View at Google Scholar · View at Scopus
  22. J. Huang, X. Fan, X. Wang et al., “High ROR2 expression in tumor cells and stroma is correlated with poor prognosis in pancreatic ductal adenocarcinoma,” Scientific Reports, vol. 5, Article ID 12991, 2015. View at Publisher · View at Google Scholar · View at Scopus
  23. C. Lu, X. Wang, H. Zhu, J. Feng, S. Ni, and J. Huang, “Over-expression of ROR2 and Wnt5a cooperatively correlates with unfavorable prognosis in patients with non-small cell lung cancer,” Oncotarget, vol. 6, no. 28, pp. 24912–24921, 2015. View at Publisher · View at Google Scholar · View at Scopus
  24. H. Zhang, M. Yao, W. Wu et al., “Up-regulation of annexin A2 expression predicates advanced clinicopathological features and poor prognosis in hepatocellular carcinoma,” Tumor Biology, vol. 36, no. 12, pp. 9373–9383, 2015. View at Publisher · View at Google Scholar · View at Scopus
  25. H. Yang, Q. Zhang, J. He, and W. Lu, “Regulation of calcium signaling in lung cancer,” Journal of Thoracic Disease, vol. 2, no. 1, pp. 52–56, 2010. View at Google Scholar · View at Scopus
  26. P. J. Cullen and P. J. Lockyer, “Integration of calcium and Ras signalling,” Nature Reviews Molecular Cell Biology, vol. 3, no. 5, pp. 339–348, 2002. View at Publisher · View at Google Scholar · View at Scopus
  27. P. Pinton and R. Rizzuto, “Bcl-2 and Ca2+ homeostasis in the endoplasmic reticulum,” Cell Death and Differentiation, vol. 13, no. 8, pp. 1409–1418, 2006. View at Publisher · View at Google Scholar · View at Scopus
  28. R. Rizzuto and T. Pozzan, “Microdomains of intracellular Ca2+: molecular determinants and functional consequences,” Physiological Reviews, vol. 86, no. 1, pp. 369–408, 2006. View at Publisher · View at Google Scholar · View at Scopus
  29. R. Rizzuto, P. Pinton, D. Ferrari et al., “Calcium and apoptosis: facts and hypotheses,” Oncogene, vol. 22, no. 53, pp. 8619–8627, 2003. View at Publisher · View at Google Scholar · View at Scopus
  30. S. Padar, C. van Breemen, D. W. Thomas, J. A. Uchizono, J. C. Livesey, and R. Rahimian, “Differential regulation of calcium homeostasis in adenocarcinoma cell line A549 and its Taxol-resistant subclone,” British Journal of Pharmacology, vol. 142, no. 2, pp. 305–316, 2004. View at Publisher · View at Google Scholar · View at Scopus
  31. K. Schrödl, H. Oelmez, M. Edelmann, R. M. Huber, and A. Bergner, “Altered Ca2-homeostasis of cisplatin-treated and low level resistant non-small-cell and small-cell lung cancer cells,” Cellular Oncology, vol. 31, no. 4, pp. 301–315, 2009. View at Publisher · View at Google Scholar · View at Scopus
  32. B. Boutin, N. Tajeddine, G. Monaco et al., “Endoplasmic reticulum Ca(2+) content decrease by PKA-dependent hyperphosphorylation of type 1 IP3 receptor contributes to prostate cancer cell resistance to androgen deprivation,” Cell Calcium, vol. 57, no. 4, pp. 312–320, 2015. View at Publisher · View at Google Scholar · View at Scopus
  33. D. D. Bikle, Y. Oda, and Z. Xie, “Calcium and 1,25(OH)2D: interacting drivers of epidermal differentiation,” Journal of Steroid Biochemistry and Molecular Biology, vol. 89-90, pp. 355–360, 2004. View at Publisher · View at Google Scholar · View at Scopus
  34. J.-B. Huang, A. L. Kindzelskii, A. J. Clark, and H. R. Petty, “Identification of channels promoting calcium spikes and waves in HT1080 tumor cells: their apparent roles in cell motility and invasion,” Cancer Research, vol. 64, no. 7, pp. 2482–2489, 2004. View at Publisher · View at Google Scholar · View at Scopus
  35. G. Amuthan, G. Biswas, H. K. Ananadatheerthavarada, C. Vijayasarathy, H. M. Shephard, and N. G. Avadhani, “Mitochondrial stress-induced calcium signaling, phenotypic changes and invasive behavior in human lung carcinoma A549 cells,” Oncogene, vol. 21, no. 51, pp. 7839–7849, 2002. View at Publisher · View at Google Scholar · View at Scopus
  36. B. T. Jacques-Fricke, Y. Seow, P. A. Gottlieb, F. Sachs, and T. M. Gomez, “Ca2+ influx through mechanosensitive channels inhibits neurite outgrowth in opposition to other influx pathways and release from intracellular stores,” The Journal of Neuroscience, vol. 26, no. 21, pp. 5656–5664, 2006. View at Publisher · View at Google Scholar · View at Scopus
  37. A. M. Patton, J. Kassis, H. Doong, and E. C. Kohn, “Calcium as a molecular target in angiogenesis,” Current Pharmaceutical Design, vol. 9, no. 7, pp. 543–551, 2003. View at Publisher · View at Google Scholar · View at Scopus
  38. M. S. Bentle, K. E. Reinicke, E. A. Bey, D. R. Spitz, and D. A. Boothman, “Calcium-dependent modulation of poly(ADP-ribose) polymerase-1 alters cellular metabolism and DNA repair,” Journal of Biological Chemistry, vol. 281, no. 44, pp. 33684–33696, 2006. View at Publisher · View at Google Scholar · View at Scopus
  39. S. Rosenberger, I. S. Thorey, S. Werner, and P. Boukamp, “A novel regulator of telomerase: S100A8 mediates differentiation-dependent and calcium-induced inhibition of telomerase activity in the human epidermal keratinocyte line HaCaT,” Journal of Biological Chemistry, vol. 282, no. 9, pp. 6126–6135, 2007. View at Publisher · View at Google Scholar · View at Scopus
  40. A. Zawadzki, Q. Liu, Y. Wang, A. Melander, B. Jeppsson, and H. Thorlacius, “Verapamil inhibits L-type calcium channel mediated apoptosis in human colon cancer cells,” Diseases of the Colon and Rectum, vol. 51, no. 11, pp. 1696–1702, 2008. View at Publisher · View at Google Scholar · View at Scopus
  41. G. L. Carboni, B. Gao, M. Nishizaki et al., “CACNA2D2-mediated apoptosis in NSCLC cells is associated with alterations of the intracellular calcium signaling and disruption of mitochondria membrane integrity,” Oncogene, vol. 22, no. 4, pp. 615–626, 2003. View at Publisher · View at Google Scholar · View at Scopus
  42. D. L. Carlisle, X. Liu, T. M. Hopkins, M. C. Swick, R. Dhir, and J. M. Siegfried, “Nicotine activates cell-signaling pathways through muscle-type and neuronal nicotinic acetylcholine receptors in non-small cell lung cancer cells,” Pulmonary Pharmacology and Therapeutics, vol. 20, no. 6, pp. 629–641, 2007. View at Publisher · View at Google Scholar · View at Scopus
  43. T. Yamamoto and A. Takahara, “Recent updates of N-type calcium channel blockers with therapeutic potential for neuropathic pain and stroke,” Current Topics in Medicinal Chemistry, vol. 9, no. 4, pp. 377–395, 2009. View at Publisher · View at Google Scholar · View at Scopus
  44. M. S. Lee, “Recent progress in the discovery and development of N-type calcium channel modulators for the treatment of pain,” Progress in Medicinal Chemistry, vol. 53, pp. 147–186, 2014. View at Publisher · View at Google Scholar · View at Scopus
  45. J. L. Groen, A. Andrade, K. Ritz et al., “CACNA1B mutation is linked to unique myoclonus-dystonia syndrome,” Human Molecular Genetics, vol. 24, no. 4, pp. 987–993, 2015. View at Publisher · View at Google Scholar · View at Scopus